AML Hub

What AML Hub does

AML Hub is an independent medical education platform dedicated exclusively to acute myeloid leukemia (AML), serving verified healthcare professionals — primarily hematologists, oncologists, and AML specialists — worldwide. The platform is operated by Scientific Education Support (SES), a UK-based medical education company headquartered in Thames Ditton, and has been active for approximately ten years. Core products include the AML Hub Educational Platform (expert-curated content on AML types, therapeutics, clinical trials, drug updates, congress coverage from ASH/EHA/EBMT/TCT, and expert opinions), My AML Hub (a personalized account feature for bookmarking, alerts, and recommendations), and a companion patient-facing site, Know AML. Editorial governance is provided by a steering committee of recognized AML clinicians including Jeffrey Lancet, Charles Craddock, Gail J. Roboz, Mark J. Levis, and Eytan Stein.

The underlying technology is a web-based content platform (aml-hub.com) with third-party integrations for Stripe payment processing and Google Translate-based machine translation of content. Distribution occurs through the website, email alerts, an active X/Twitter handle (@AML_Hub), and live coverage at major hematology congresses.

AML Hub does not charge HCPs; its revenue model is sponsorship-based. The platform is funded by pharmaceutical companies — Johnson & Johnson at the GOLD tier, Daiichi Sankyo, Kura Oncology, and Thermo Fisher Scientific at the BRONZE tier, and Syndax and AbbVie as Contributors — supplemented by individual one-off and recurring contributions processed via Stripe. Funders are explicitly granted no editorial influence. The platform maintains a strategic partnership with the European LeukemiaNet (ELN) for guideline alignment. The company is privately held with 11-50 employees and no disclosed revenue or funding rounds.

Name

AML Hub

Legal name

AML Hub

Website

https://aml-hub.com

Company type

Private

Founded year

2016

Operating status

Operating

Headcount range

11–50 employees

Short description

AML Hub is an independent, pharma-sponsored medical education platform operated by Scientific Education Support, providing expert-curated AML content, congress coverage, and clinical trial updates to verified hematologists and oncologists worldwide through its web platform.

Ownership category

akta.pro rank

Product category

Continuing Medical Education

NAICS

Other Scientific and Technical Consulting Services (54169)

SIC

Services-Misc Health & Allied Services, Nec (8090)

akta.pro primary industry

KOL Engagement & Medical Education (Advisory Boards/CME Support) (HLAGALAM)

Keywords

• Medical education platform
• Oncology educational resources
• AML clinical content
• Hematology training resources
• Healthcare professional education

Headquarters

HQ city

Thames Ditton

HQ country

United Kingdom

HQ region

Europe

Markets served

GTM type

B2B

Offering type

Digital Commerce or Content

Cost components

Personnel, Technology or R&D, Marketing or Sales, Operations, Others

Distribution channels1 record

Marketing channels5 records

Core offering

AML Hub is an independent medical education platform providing expertly curated clinical content on Acute Myeloid Leukemia (AML) for verified healthcare professionals. Content includes expert interviews, clinical trial summaries, drug approval updates, congress coverage (ASH, EHA, EBMT, TCT), therapeutic class updates (FLT3 inhibitors, menin inhibitors, hypomethylating agents, BCL-2 inhibitors), and steering committee deliberations, organized around Types, Therapeutics, Congresses, Trials, Expert Opinions, Drug Updates, and Educational Resources. The platform is operated by Scientific Education Support (SES) under editorial governance by a multidisciplinary steering committee of globally recognized AML experts, funded by pharmaceutical sponsors without editorial influence.

Product overview

AML Hub is a medical education platform consisting of the core AML Hub Educational Platform and the personalized My AML Hub feature. The platform provides curated content on AML types, therapeutics (including FLT3 inhibitors, menin inhibitors, hypomethylating agents), clinical trials, congress coverage (ASH, EHA, EBMT), expert opinions, drug updates, and steering committee meetings. A companion platform called Know AML serves patients and carers separately.

Differentiator

Problem solved

Functional benefit

Products and services

• AML Hub Educational Platform Independent medical education platform providing expertly curated content for healthcare professionals on Acute Myeloid Leukemia (AML), including information on AML types, therapeutics (FLT3 inhibitors, menin inhibitors, hypomethylating agents, BCL-2 inhibitors), congresses (ASH, EHA, EBMT, TCT), clinical trials, expert opinions, drug updates, and educational resources.
• My AML Hub

Segments1 record

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration2 records

Partnerships

Two partnerships are on record, tiered core.

• Scientific Education Support (SES)coreStrategic or Co-development PartnerThe AML Hub is operated by Scientific Education Support (SES), which develops and manages all platform content in collaboration with the expert steering committee. SES ensures independent editorial governance while the platform is funded by pharmaceutical companies.
• European LeukemiaNet (ELN)coreStrategic or Co-development PartnerThe AML Hub operates in partnership with the European LeukemiaNet, with the ELN logo displayed on the platform. The partnership supports the platform's alignment with ELN risk classifications and treatment guidelines referenced throughout AML Hub content.

Scale indicators1 record

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• Medscape: Medscape is the largest generalist HCP medical education and news platform, with deep oncology/hematology content funded by pharma. It competes with AML Hub for HCP attention but at a much broader, multi-specialty scale.
• Springer Healthcare: Springer Healthcare, part of Springer Nature, delivers pharma-funded medical communications and education across multiple therapeutic areas. It is comparable to AML Hub in delivering pharma-supported HCP content, but at much greater scale and across many indications.
• American Society of Hematology (ASH) Education Program: ASH is the leading professional society for hematology and provides authoritative hematology education and congress content. It is comparable as an authoritative HCP educational resource in AML, though it is society- rather than sponsor-driven and not a single-disease platform.
• European Hematology Association (EHA) Learning: EHA provides hematology education, congress content (EHA Congress), and guideline-aligned resources for European hematologists. It overlaps with AML Hub's audience and congress coverage role, but as a professional society rather than a dedicated AML platform.

Direct peers

• Clinical Care Options (CCO): Clinical Care Options is a medical education company producing CME-certified activities for specialists, including hematology/oncology. It is comparable to AML Hub as a pharma-funded, expert-authored CME platform targeting specialist clinicians.
• Targeted Oncology: Targeted Oncology delivers oncology news, conference coverage, and educational content to practicing oncologists. It shares AML Hub's HCP audience, congress coverage, and pharma sponsorship model, while operating at a broader oncology scope.
• OncLive: OncLive is an oncology-focused medical education platform serving hematologists/oncologists with expert interviews, congress coverage, and CME content. It is directly comparable to AML Hub as a pharma-supported HCP education destination, though it spans all oncology rather than a single disease.
• International Medical Press: International Medical Press delivers CME-accredited medical education across therapeutic areas including hematology. It is a comparable specialist-focused, pharma-sponsored HCP education provider with similar content and distribution mechanics.
• VJOncology: VJOncology provides video-based hematology/oncology education for clinicians, featuring KOL interviews and congress highlights. It is comparable to AML Hub in audience (HCPs), format (expert video), and sponsorship model, though distributed across multiple tumor types.
• PRIME Oncology: PRIME Oncology provides accredited continuing education for oncology professionals, supported by independent educational grants from pharma. It mirrors AML Hub's model of independent, expert-led, sponsor-funded oncology education.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/AML_Hub
• Facebookfacebook.com/AMLHub

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about AML Hub